Real-time enrollment status for this myeloid malignancy clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:03 PM UTC
| NCT Number | NCT06594445 |
| Recruiting Status | Recruiting |
| Condition | Myeloid Malignancy |
| Phase | PHASE1 |
| Target Enrollment | 45 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Masonic Cancer Center, University of Minnesota |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of October 12, 2026: Clinical trial NCT06594445 is currently recruiting participants. This phase1 study for myeloid malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by Masonic Cancer Center, University of Minnesota. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06594445 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06594445 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.